Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Cancer Therapies02:49

Cancer Therapies

7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.1K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

162
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
162

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting therapeutic responses in metastatic colorectal cancer through personalized functional profiling of patient-derived spheroids.

NPJ precision oncology·2026
Same author

Advancing CNS tumor diagnostics with expanded DNA methylation-based classification.

Cancer cell·2025
Same author

Fusobacterium nucleatum interacts with cancer-associated fibroblasts to promote colorectal cancer.

The EMBO journal·2025
Same author

Advancing sarcoma diagnostics with expanded DNA methylation-based classification.

medRxiv : the preprint server for health sciences·2025
Same author

Modulation of the ACOD1/itaconate pathway differentially affects atherosclerosis severity across genetic models and sexes.

The Journal of clinical investigation·2025
Same author

Advancing CNS tumor diagnostics with expanded DNA methylation-based classification.

medRxiv : the preprint server for health sciences·2025

Related Experiment Video

Updated: May 16, 2025

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
09:36

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Published on: June 28, 2019

9.8K

Neurooncology: 2025 update.

Michel Mittelbronn1,2

  • 1Department of Life Sciences and Medicine (DLSM), University of Luxembourg; Esch sur Alzette, Luxembourg.

Free Neuropathology
|April 2, 2025
PubMed
Summary
This summary is machine-generated.

Recent brain tumor research reveals key insights into the tumor microenvironment, epigenetics, and immune interactions. Advanced diagnostics like cell-free DNA sequencing offer improved patient prognoses and personalized neuro-oncology treatments.

Keywords:
Brain metastasisBrain tumorsGlioblastomaNeurooncologyNeuropathology

More Related Videos

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.4K
Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice
05:39

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice

Published on: December 27, 2024

280

Related Experiment Videos

Last Updated: May 16, 2025

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
09:36

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Published on: June 28, 2019

9.8K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.4K
Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice
05:39

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice

Published on: December 27, 2024

280

Area of Science:

  • Neuro-oncology
  • Cancer Biology
  • Epigenetics

Background:

  • Brain tumor research is advancing, focusing on primary CNS tumors and brain metastasis.
  • The tumor microenvironment, including cerebral microcirculation and hypoxia, significantly impacts metastatic progression.
  • Glioblastoma exhibits intratumoral heterogeneity and distinct DNA methylation profiles, crucial for understanding tumor evolution.

Purpose of the Study:

  • To highlight groundbreaking advancements in brain tumor research, focusing on the tumor microenvironment, epigenetics, and diagnostics.
  • To explore the role of DNA methylation and histone serotonylation in glioblastoma and ependymoma.
  • To present novel diagnostic and prognostic tools for improved patient care in neuro-oncology.

Main Methods:

  • Analysis of DNA methylation profiles in recurrent glioblastoma.
  • Investigation of the immune landscape and cell dynamics using single-cell phenotyping.
  • Application of confocal laser microscopy and cerebrospinal fluid-derived cell-free DNA sequencing for diagnostics.

Main Results:

  • Global DNA methylation identified as a diagnostic marker for IDH-wildtype glioblastoma.
  • Histone serotonylation confirmed as a critical epigenetic regulator in ependymoma.
  • Advanced histomorphological features and non-invasive liquid biopsies show promise for prognosis and diagnosis.

Conclusions:

  • Understanding the tumor microenvironment, epigenetic modifications, and immune interactions is vital for brain tumor progression.
  • Innovative diagnostic and prognostic tools are enhancing patient care and enabling personalized treatment strategies.
  • These advancements represent significant progress in neuro-oncology, aiming for improved outcomes in brain tumor patients.